JACOB BAILEY: Open Payments
NPI 1780363275 · WESTERVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$779 in 37 payments from 15 companies in 2025. Trend: 2023 $248 · 2024 $1,308 · 2025 $779
Food & beverage: $779
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $156 |
| Gilead Sciences, Inc. | 1 | $128 |
| Novo Nordisk Inc | 5 | $84 |
| PFIZER INC. | 4 | $75 |
| AstraZeneca Pharmaceuticals LP | 4 | $61 |
| Astellas Pharma US Inc | 2 | $57 |
| Lilly USA, LLC | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Boston Scientific Corporation | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: Yeztugo, QULIPTA, Veozah, NURTEC ODT, JARDIANCE, Rybelsus, AIRSUPRA, UBRELVY.
Industry payments across OH — which companies pay providers there.
